Toxicity of amyloid aggregation samples in human neuroblastoma cells
Cell-based study · human neuroblastoma cells (SH-SY5Y) [1]
In the absence of bexarotene, the species formed after incubation for 0.3 hours and 4 hours exhibited a level of toxicity 65 ± 5% higher than that in the presence of bexarotene. However, for the samples incubated for 7 hours, the level of toxicity generated in the presence of bexarotene increased to a value similar to that observed in its absence whereas the toxicity of Aβ alone decreased.
| Endpoint | Reported result | Reference |
|---|---|---|
| activity of caspase-3 | caspase-3 activity a level of toxicity 65 ± 5% higher than that in the presence of bexarotene | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 20-fold excess (that is, 10 μM)
- Exposure duration
- after incubation for 0.3 hours (Fig. 5D) and 4 hours (Fig. 5E); an additional 24 hours
- Method
- Aliquots of Aβ42 solutions were removed at different time points during the lag phase of the aggregation reaction in the absence and presence of bexarotene and incubated with SH-SY5Y neuroblastoma cells
- Vehicle
- 1% DMSO final concentration
- Co-treatment
- Other interventions in this design: Aβ42 0.5 μM. Compound effect isolated by the comparison: Aβ42 in the absence and in the presence of bexarotene.
Methods and source locations
Compound reported in the paper: Bexarotene
Evidence for Bexarotene as the phosphate form reported in the paper, not the free base/neutral form supplied as A11094; no salt equivalence, dose conversion or lot validation.
RESULTS > Targeting primary nucleation delays the formation of toxic species of Aβ42 (S76, S79, S81, S82); MATERIALS AND METHODS > Caspase-3 cytotoxicity assay (S174, S178, S183, S184, S189, S194)
activity of caspase-3: activity of caspase-3; comparator: Aβ either alone — RESULTS > Targeting primary nucleation delays the formation of toxic species of Aβ42 (S81, S82); MATERIALS AND METHODS > Caspase-3 cytotoxicity assay (S174)